Alessandro Di Maria

Title: Alessandro Di Maria: Innovator in Pharmaceutical Formulations

Introduction

Alessandro Di Maria is a notable inventor based in Lugano, Switzerland. He has made significant contributions to the field of pharmaceutical formulations, particularly focusing on amino acids, peptides, and proteins. His innovative work has led to the development of a unique patent that addresses critical aspects of pharmaceutical formulation stability.

Latest Patents

Alessandro holds a patent for "Stable pharmaceutical formulations of amino acids, peptides or proteins." This patent describes pharmaceutical formulations that include an active ingredient from the amino acid, peptide, or protein classes, combined with glycerin as an excipient. Notably, the glycerin used in these formulations is characterized by an iron content of ≤0.2 ppm and an aldehyde and/or ketone species content of ≤5 ppm. This innovation is crucial for enhancing the stability and efficacy of pharmaceutical products.

Career Highlights

Alessandro Di Maria is currently associated with Ibsa Institut Biochimique SA, a company known for its commitment to research and development in the pharmaceutical sector. His work at Ibsa has allowed him to explore and implement advanced formulations that improve patient outcomes.

Collaborations

Alessandro collaborates with Tiziano Fossati, a fellow professional in the field. Their partnership exemplifies the collaborative spirit that drives innovation in pharmaceutical research.

Conclusion

Alessandro Di Maria's contributions to pharmaceutical formulations highlight his role as an innovator in the industry. His patent for stable formulations demonstrates his commitment to improving the quality and effectiveness of pharmaceutical products.